These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 9812122

  • 1. A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects.
    Bartha R, Stein MB, Williamson PC, Drost DJ, Neufeld RW, Carr TJ, Canaran G, Densmore M, Anderson G, Siddiqui AR.
    Am J Psychiatry; 1998 Nov; 155(11):1584-91. PubMed ID: 9812122
    [Abstract] [Full Text] [Related]

  • 2. Striatal structure and its association with N-Acetylaspartate and glutamate in autism spectrum disorder and obsessive compulsive disorder.
    Naaijen J, Zwiers MP, Forde NJ, Williams SC, Durston S, Brandeis D, Glennon JC, The Tactics Consortium, Franke B, Lythgoe DJ, Buitelaar JK.
    Eur Neuropsychopharmacol; 2018 Jan; 28(1):118-129. PubMed ID: 29169826
    [Abstract] [Full Text] [Related]

  • 3. 1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for neuronal loss in the cingulate gyrus and the right striatum.
    Ebert D, Speck O, König A, Berger M, Hennig J, Hohagen F.
    Psychiatry Res; 1997 Jul 04; 74(3):173-6. PubMed ID: 9255862
    [Abstract] [Full Text] [Related]

  • 4. Shape deformity of the corpus striatum in obsessive-compulsive disorder.
    Choi JS, Kim SH, Yoo SY, Kang DH, Kim CW, Lee JM, Kim IY, Kim SI, Kim YY, Kwon JS.
    Psychiatry Res; 2007 Aug 15; 155(3):257-64. PubMed ID: 17572074
    [Abstract] [Full Text] [Related]

  • 5. Neurochemistry of the hippocampus in patients with obsessive-compulsive disorder.
    Atmaca M, Yildirim H, Ozdemir H, Koc M, Ozler S, Tezcan E.
    Psychiatry Clin Neurosci; 2009 Aug 15; 63(4):486-90. PubMed ID: 19531109
    [Abstract] [Full Text] [Related]

  • 6. Mapping structural brain alterations in obsessive-compulsive disorder.
    Pujol J, Soriano-Mas C, Alonso P, Cardoner N, Menchón JM, Deus J, Vallejo J.
    Arch Gen Psychiatry; 2004 Jul 15; 61(7):720-30. PubMed ID: 15237084
    [Abstract] [Full Text] [Related]

  • 7. Assessment of glutamate in striatal subregions in obsessive-compulsive disorder with proton magnetic resonance spectroscopy.
    Simpson HB, Kegeles LS, Hunter L, Mao X, Van Meter P, Xu X, Kimeldorf MB, Pearlstein SL, Slifstein M, Shungu DC.
    Psychiatry Res; 2015 Apr 30; 232(1):65-70. PubMed ID: 25715904
    [Abstract] [Full Text] [Related]

  • 8. Comparing brain magnetic resonance spectroscopy findings of pediatric treatment-naive obsessive-compulsive disorder patients with healthy controls.
    Yalçın O, Sener S, Konuş Boyunağa OL, Sarıpınar EG, Oğur T, Güney E, Akın Sarı B, Işeri E.
    Turk Psikiyatri Derg; 2011 Apr 30; 22(4):222-9. PubMed ID: 22143947
    [Abstract] [Full Text] [Related]

  • 9. 1H magnetic resonance spectroscopy evidence for occipital involvement in treatment-naive paediatric obsessive-compulsive disorder.
    Ljungberg M, Nilsson MKL, Melin K, Jönsson L, Carlsson A, Carlsson Å, Forssell-Aronsson E, Ivarsson T, Carlsson M, Starck G.
    Acta Neuropsychiatr; 2017 Jun 30; 29(3):179-190. PubMed ID: 27772535
    [Abstract] [Full Text] [Related]

  • 10. Metabolic alterations in medication-free patients with bipolar disorder: a 3T CSF-corrected magnetic resonance spectroscopic imaging study.
    Port JD, Unal SS, Mrazek DA, Marcus SM.
    Psychiatry Res; 2008 Feb 28; 162(2):113-21. PubMed ID: 18164911
    [Abstract] [Full Text] [Related]

  • 11. Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder.
    Yücel M, Wood SJ, Wellard RM, Harrison BJ, Fornito A, Pujol J, Velakoulis D, Pantelis C.
    Aust N Z J Psychiatry; 2008 Jun 28; 42(6):467-77. PubMed ID: 18465373
    [Abstract] [Full Text] [Related]

  • 12. Clinical correlates of caudate volume in drug-naïve adult patients with obsessive-compulsive disorder.
    Narayanaswamy JC, Jose DA, Kalmady SV, Venkatasubramanian G, Janardhana Reddy YC.
    Psychiatry Res; 2013 Apr 30; 212(1):7-13. PubMed ID: 23489673
    [Abstract] [Full Text] [Related]

  • 13. Functional and biochemical alterations of the medial frontal cortex in obsessive-compulsive disorder.
    Yücel M, Harrison BJ, Wood SJ, Fornito A, Wellard RM, Pujol J, Clarke K, Phillips ML, Kyrios M, Velakoulis D, Pantelis C.
    Arch Gen Psychiatry; 2007 Aug 30; 64(8):946-55. PubMed ID: 17679639
    [Abstract] [Full Text] [Related]

  • 14. Brain magnetic resonance spectroscopy in obsessive-compulsive disorder: the importance of considering subclinical symptoms of anxiety and depression.
    Bédard MJ, Chantal S.
    Psychiatry Res; 2011 Apr 30; 192(1):45-54. PubMed ID: 21377338
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A 1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: relationship between metabolite concentrations and symptom severity.
    Starck G, Ljungberg M, Nilsson M, Jönsson L, Lundberg S, Ivarsson T, Ribbelin S, Ekholm S, Carlsson A, Forssell-Aronsson E, Carlsson ML.
    J Neural Transm (Vienna); 2008 Jul 30; 115(7):1051-62. PubMed ID: 18528631
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Volumetric investigation of the frontal-subcortical circuitry in patients with obsessive-compulsive disorder.
    Kang DH, Kim JJ, Choi JS, Kim YI, Kim CW, Youn T, Han MH, Chang KH, Kwon JS.
    J Neuropsychiatry Clin Neurosci; 2004 Jul 30; 16(3):342-9. PubMed ID: 15377742
    [Abstract] [Full Text] [Related]

  • 19. White matter abnormalities of fronto-striato-thalamic circuitry in obsessive-compulsive disorder: A study using diffusion spectrum imaging tractography.
    Chiu CH, Lo YC, Tang HS, Liu IC, Chiang WY, Yeh FC, Jaw FS, Tseng WY.
    Psychiatry Res; 2011 Jun 30; 192(3):176-82. PubMed ID: 21546223
    [Abstract] [Full Text] [Related]

  • 20. 1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: effects of 12 weeks of sertraline treatment on brain metabolites.
    Tükel R, Aydın K, Ertekin E, Özyıldırım SŞ, Barburoğlu M.
    Eur Arch Psychiatry Clin Neurosci; 2015 Apr 30; 265(3):219-26. PubMed ID: 25256264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.